Inventor · disambiguated record
Bing Zhou
Also filed as: ZHOU BING · ZHOU BING-SEN
24 granted patents·7 pending applications·88 citations·filing 2002–2024
94Inventor score
Files withUNIV MICHIGAN REGENTS14SHANGHAI INST MATERIA MEDICA CAS8HOPE CITY1MAGELLAN PHARMA CO LTD1SHANGHAI PRET COMPOSITES CO1
Top patents by PatentIndex Score
31 records- 0194US10307407B29H-pyrimido [4,5-B] indoles as BET bromodomain inhibitorsUNIV MICHIGAN REGENTS·Filed 2016·Granted Jun 4, 2019·11 cites·6 claims
- 0294US10253044B29H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitorsUNIV MICHIGAN REGENTS·Filed 2017·Granted Apr 9, 2019·11 cites·14 claims
- 0390US9580430B29H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitorsUNIV MICHIGAN REGENTS·Filed 2015·Granted Feb 28, 2017·7 cites·18 claims
- 0489US9675697B2BET bromodomain inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2014·Granted Jun 13, 2017·16 cites·21 claims
- 0588US7956076B2Ribonucleotide reductase inhibitors and methods of useHOPE CITY·Filed 2009·Granted Jun 7, 2011·9 cites·7 claims
- 0685US10391175B2BET bromodomain inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2017·Granted Aug 27, 2019·6 cites·18 claims
- 0783US8163783B2Ribonucleotide reductase inhibitors and methods of useYEN YUN·Filed 2011·Granted Apr 24, 2012·6 cites·8 claims
- 0881US12065447B2Heterocyclic amide for inhibiting RIP1 kinase and uses thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Granted Aug 20, 2024·1 cites·9 claims
- 0980US10689434B2Antibody against hepatitis B surface antigen and use thereofUNIV XIAMEN·Filed 2016·Granted Jun 23, 2020·2 cites·17 claims
- 1079US10759808B2Monofunctional intermediates for ligand-dependent target protein degradationUNIV MICHIGAN REGENTS·Filed 2017·Granted Sep 1, 2020·2 cites·20 claims
- 1178US11192898B2MDM2 protein degradersUNIV MICHIGAN REGENTS·Filed 2017·Granted Dec 7, 2021·1 cites·7 claims
- 1275US7078485B2N-terminal modified recombinant human endostatin and its productionYANTAI MEDGENN LTD·Filed 2002·Granted Jul 18, 2006·8 cites·12 claims
- 1374US9403892B2Therapeutic TRAIL fusion protein and preparation and use thereofMAGELLAN PHARMA CO LTD·Filed 2014·Granted Aug 2, 2016·4 cites·14 claims
- 1471US11498927B2Heterocyclic amide for inhibiting RIP1 kinase and uses thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2019·Granted Nov 15, 2022·2 cites·9 claims
- 1571US11319303B2Compound used as autophagy regulator, and preparation method therefor and uses thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2018·Granted May 3, 2022·1 cites·6 claims
- 1666US11013745B2Triazolopyrimidine, triazolopyridine compounds, and the composition thereof for treating PRC2-mediated diseasesSHANGHAI INST MATERIA MEDICA CAS·Filed 2018·Granted May 25, 2021·1 cites·18 claims
- 1761US2022411432A1Mdm2 protein degradersUNIV MICHIGAN REGENTS·Filed 2021·Application pending·0 cites
- 1859US2022356192A1Fused 1,4-diazepines as bet protein degradersUNIV MICHIGAN REGENTS·Filed 2021·Application pending·0 cites
- 1958US12151204B1Catalytic oxidation system for efficient conversion and removal of volatile organic compounds (VOCs) in coal chemical industry, and catalytic oxidation method thereofUNIV ZHEJIANG·Filed 2024·Granted Nov 26, 2024·0 cites·15 claims
- 2058US11911477B2Use of fructose in preparing drug for treating ischemic injuryUNIV BEIHANG·Filed 2022·Granted Feb 27, 2024·0 cites·18 claims
- 2157US2021002289A1Monofunctional intermediates for ligand-dependent target protein degradationUNIV MICHIGAN REGENTS·Filed 2020·Application pending·0 cites
- 2255US2024093030A1High-strength and high-heat-resistant bio-based polyamide composition and preparation method thereofSHANGHAI PRET COMPOSITES CO·Filed 2021·Application pending·0 cites
- 2355US2024270753A1Heterocyclic compound for inhibiting shp2 activity, preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 2450US10975093B2Fused 1,4-diazepines as BET protein degradersUNIV MICHIGAN REGENTS·Filed 2017·Granted Apr 13, 2021·0 cites·19 claims
- 2549US2024059676A1THYROID HORMONE RECEPTOR b SELECTIVE AGONIST COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOFSHANGHAI INST MATERIA MEDICA CAS·Filed 2021·Application pending·0 cites
- 2649US2025289812A1Compound for treating thrombotic diseasesSHANGHAI INST MATERIA MEDICA CAS·Filed 2021·Application pending·0 cites
- 2747US11548899B2Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitorsUNIV MICHIGAN REGENTS·Filed 2017·Granted Jan 10, 2023·0 cites·16 claims
- 2843US12172989B2Histone acetyltransferase (HAT) inhibitor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Granted Dec 24, 2024·0 cites·17 claims
- 2939US11466028B2Fused 1,4-oxazepines as BET protein degradersUNIV MICHIGAN REGENTS·Filed 2017·Granted Oct 11, 2022·0 cites·19 claims
- 3039US11427593B2Bromodomain inhibitor compound and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2019·Granted Aug 30, 2022·0 cites·13 claims
- 3138US10633386B2BET protein degradersUNIV MICHIGAN REGENTS·Filed 2017·Granted Apr 28, 2020·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →